Cancer Clinical Investigation

Search results

• Researchers from Icahn School of Medicine at Mount Sinai Report Findings in Breast Cancer (Mixcan: a Framework for Cell-type-aware Transcriptome-wide Association Studies With an Application To Breast Cancer)

  Wang, P., Song, X., Sieh, W. & Sistig, A.

  18/05/23

  1 item of Media coverage

  Press/Media

• Cancer Action Network: Oncologists Call for Improvements in Access to Biomarker Testing as Assembly Insurance Committee Signals Unanimous Support

  Sfakianos, J.

  18/05/23

  1 item of Media coverage

  Press/Media

• ONCOLOGISTS CALL FOR IMPROVEMENTS IN ACCESS TO BIOMARKER TESTING AS ASSEMBLY INSURANCE COMMITTEE SIGNALS UNANIMOUS SUPPORT

  Sfakianos, J.

  17/05/23

  1 item of Media coverage

  Press/Media

• Small pancreatic cancer vaccine trial shows promise

  Bhardwaj, N.

  17/05/23

  1 item of Media coverage

  Press/Media

• Pelabresib Plus Ruxolitinib for Patients With JAK Inhibitor Naïve Myelofibrosis

  Mascarenhas, J.

  16/05/23

  1 item of Media coverage

  Press/Media

• The Pershing Square Sohn Cancer Research Alliance Celebrates Its 10th Anniversary

  Skobe, M., Aguirre-Ghiso, J., Bernstein, E., Parsons, R. & Bhardwaj, N.

  16/05/23

  6 items of Media coverage

  Press/Media

• Mount Sinai Leaders Ashutosh Tewari, MBBS, MCh; Pamela Abner, MPA, CPXP; Scott Lorin, MD, MBA, and Kristin Myers Named to Crain's 2023 Notable Health Care Leaders List

  Davis, K. L., Tewari, A. & Lorin, S. M.

  15/05/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Leaders Ashutosh Tewari, MBBS, MCh; Pamela Abner, MPA, CPXP; Scott Lorin, MD, MBA, and Kristin Myers Named to Crain's 2023 Notable Health Care Leaders List

  Davis, K. L., Tewari, A. & Lorin, S. M.

  15/05/23

  1 item of Media coverage

  Press/Media

• Investigators at Icahn School of Medicine at Mount Sinai Detail Findings in Personalized Medicine (Multiparametric Mri of Solid Renal Masses: Principles and Applications of Advanced Quantitative and Functional Methods for Tumor Diagnosis and ...)

  Badani, K., Lewis, S., Taouli, B. & Bane, O.

  11/05/23

  1 item of Media coverage

  Press/Media

• Pancreatic cancer vaccine shows promise in small trial

  Bhardwaj, N.

  10/05/23

  2 items of Media coverage

  Press/Media

• Pancreatic Cancer Vaccine Shows Promise in Small Trial

  Bhardwaj, N.

  10/05/23

  4 items of Media coverage

  Press/Media

• Georgetown University Researcher Describes Advances in Multiple Myeloma (What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study)

  Jagannath, S.

  10/05/23

  1 item of Media coverage

  Press/Media

• U.S. Patents Awarded to Inventors in Pennsylvania (May 10)

  Jin, J.

  10/05/23

  1 item of Media coverage

  Press/Media

• US Patent Issued to GlaxoSmithKline on May 9 for "Prolyl hydroxylase inhibitors" (Pennsylvania Inventors)

  Jin, J.

  10/05/23

  1 item of Media coverage

  Press/Media

• VIDEO: Neoadjuvant, adjuvant studies show promise in preventing HCC recurrence

  Marron, T.

  10/05/23

  1 item of Media coverage

  Press/Media

• Prolyl Hydroxylase Inhibitors

  Jin, J.

  9/05/23

  1 item of Media coverage

  Press/Media

• Increased Besremi Dose to Be Studied for Polycythemia Vera Treatment

  Mascarenhas, J.

  9/05/23

  1 item of Media coverage

  Press/Media

• VIDEO: Following up IMbrave050 study will be important in hepatocellular carcinoma

  Marron, T.

  9/05/23

  1 item of Media coverage

  Press/Media

• VIDEO: Circulating tumor DNA levels could help predict hepatocellular carcinoma recurrence

  Marron, T.

  9/05/23

  1 item of Media coverage

  Press/Media

• Studies in the Area of Cancer Reported from Memorial Sloan-Kettering Cancer Center (Rapid cancer cell perineural invasion utilizes amoeboid migration)

  Bakst, R. & Powers, A.

  8/05/23

  1 item of Media coverage

  Press/Media

• MorphoSys AG (MOR) Q1 2023 Earnings Call Transcript

  Mascarenhas, J.

  6/05/23

  1 item of Media coverage

  Press/Media

• Immunotherapy After Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer

  Galsky, M.

  5/05/23

  1 item of Media coverage

  Press/Media

• PharmaEssentia Initiates Phase 3b Trial of ropeginterferon alfa-2b-njft Investigating New Dosing Regimen for Patients with Polycythemia Vera (PV)

  Mascarenhas, J.

  3/05/23

  1 item of Media coverage

  Press/Media

• PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)

  Mascarenhas, J.

  3/05/23

  1 item of Media coverage

  Press/Media

• PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV); Single-arm trial will evaluate an accelerated dosing schedule

  Mascarenhas, J.

  2/05/23 → 3/05/23

  12 items of Media coverage

  Press/Media